These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 17339608)
21. The inhibitory effect of piperine from Fructus piperis extract on the degranulation of RBL-2H3 cells. Huang J; Zhang T; Han S; Cao J; Chen Q; Wang S Fitoterapia; 2014 Dec; 99():218-26. PubMed ID: 25307563 [TBL] [Abstract][Full Text] [Related]
22. Inhibitory effects of costunolide isolated from Laurus nobilis on IgE-induced degranulation of mast cell-like RBL-2H3 cells and the growth of Y16 pro-B cells. Kim TJ; Nam KW; Kim B; Lee SJ; Oh KB; Kim KH; Mar W; Shin J Phytother Res; 2011 Sep; 25(9):1392-7. PubMed ID: 21674633 [TBL] [Abstract][Full Text] [Related]
23. Nonpsychotropic cannabinoids, abnormal cannabidiol and canabigerol-dimethyl heptyl, act at novel cannabinoid receptors to reduce intraocular pressure. Szczesniak AM; Maor Y; Robertson H; Hung O; Kelly ME J Ocul Pharmacol Ther; 2011 Oct; 27(5):427-35. PubMed ID: 21770780 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of the IgE-mediated activation of RBL-2H3 cells by TIPP, a novel thymic immunosuppressive pentapeptide. Lian Q; Cheng Y; Zhong C; Wang F Int J Mol Sci; 2015 Jan; 16(1):2252-68. PubMed ID: 25608657 [TBL] [Abstract][Full Text] [Related]
25. Investigation into the effects of amyloid (1-42) beta-peptide upon basal and antigen-stimulated hexosaminidase and serotonin release from rat RBL-2H3 basophilic leukemia cells. Englund P; Jacobsson SO; Fowler CJ Methods Find Exp Clin Pharmacol; 2000 Nov; 22(9):657-61. PubMed ID: 11294005 [TBL] [Abstract][Full Text] [Related]
26. Cross-tolerance between delta-9-tetrahydrocannabinol and the cannabimimetic agents, CP 55,940, WIN 55,212-2 and anandamide. Pertwee RG; Stevenson LA; Griffin G Br J Pharmacol; 1993 Dec; 110(4):1483-90. PubMed ID: 8306090 [TBL] [Abstract][Full Text] [Related]
27. Atomic force microscopy study of ionomycin-induced degranulation in RBL-2H3 cells. Pi J; Huang L; Yang F; Jiang J; Jin H; Liu J; Su X; Wu A; Cai H; Yang P; Cai J Scanning; 2016 Nov; 38(6):525-534. PubMed ID: 26840764 [TBL] [Abstract][Full Text] [Related]
28. Pharmacological effects of cannabinoids on the Caco-2 cell culture model of intestinal permeability. Alhamoruni A; Lee AC; Wright KL; Larvin M; O'Sullivan SE J Pharmacol Exp Ther; 2010 Oct; 335(1):92-102. PubMed ID: 20592049 [TBL] [Abstract][Full Text] [Related]
29. Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors. Espejo-Porras F; Fernández-Ruiz J; Pertwee RG; Mechoulam R; García C Neuropharmacology; 2013 Dec; 75():155-63. PubMed ID: 23924692 [TBL] [Abstract][Full Text] [Related]
30. Effects of cannabinoid receptor agonists on immunologically induced histamine release from rat peritoneal mast cells. Lau AH; Chow SS Eur J Pharmacol; 2003 Mar; 464(2-3):229-35. PubMed ID: 12620517 [TBL] [Abstract][Full Text] [Related]
31. Correlation between cytosolic calcium concentration and degranulation in RBL-2H3 cells in the presence of various concentrations of antigen-specific IgEs. Aketani S; Teshima R; Umezawa Y; Sawada J Immunol Lett; 2001 Jan; 75(3):185-9. PubMed ID: 11166374 [TBL] [Abstract][Full Text] [Related]
32. IgE alone-induced actin assembly modifies calcium signaling and degranulation in RBL-2H3 mast cells. Oka T; Hori M; Tanaka A; Matsuda H; Karaki H; Ozaki H Am J Physiol Cell Physiol; 2004 Feb; 286(2):C256-63. PubMed ID: 13679305 [TBL] [Abstract][Full Text] [Related]
33. Analogues and homologues of N-palmitoylethanolamide, a putative endogenous CB(2) cannabinoid, as potential ligands for the cannabinoid receptors. Lambert DM; DiPaolo FG; Sonveaux P; Kanyonyo M; Govaerts SJ; Hermans E; Bueb J; Delzenne NM; Tschirhart EJ Biochim Biophys Acta; 1999 Sep; 1440(2-3):266-74. PubMed ID: 10521710 [TBL] [Abstract][Full Text] [Related]
34. Effects of Cannabidiol, ∆9-Tetrahydrocannabinol, and WIN 55-212-22 on the Viability of Canine and Human Non-Hodgkin Lymphoma Cell Lines. Omer S; Pathak S; Mansour M; Nadar R; Bowen D; Dhanasekaran M; Pondugula SR; Boothe D Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672512 [TBL] [Abstract][Full Text] [Related]
35. Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study. Oviedo A; Glowa J; Herkenham M Brain Res; 1993 Jul; 616(1-2):293-302. PubMed ID: 8395305 [TBL] [Abstract][Full Text] [Related]
36. Cannabidiol reduced the striatal atrophy caused 3-nitropropionic acid in vivo by mechanisms independent of the activation of cannabinoid, vanilloid TRPV1 and adenosine A2A receptors. Sagredo O; Ramos JA; Decio A; Mechoulam R; Fernández-Ruiz J Eur J Neurosci; 2007 Aug; 26(4):843-51. PubMed ID: 17672854 [TBL] [Abstract][Full Text] [Related]
37. Comparison of the discriminative stimulus and response rate effects of Wiley JL; Lefever TW; Marusich JA; Craft RM Drug Alcohol Depend; 2017 Mar; 172():51-59. PubMed ID: 28130989 [TBL] [Abstract][Full Text] [Related]
38. Xestospongin C, a novel blocker of IP3 receptor, attenuates the increase in cytosolic calcium level and degranulation that is induced by antigen in RBL-2H3 mast cells. Oka T; Sato K; Hori M; Ozaki H; Karaki H Br J Pharmacol; 2002 Apr; 135(8):1959-66. PubMed ID: 11959799 [TBL] [Abstract][Full Text] [Related]
39. Behavioral effects of cannabinoids show differential sensitivity to cannabinoid receptor blockade and tolerance development. De Vry J; Jentzsch KR; Kuhl E; Eckel G Behav Pharmacol; 2004 Feb; 15(1):1-12. PubMed ID: 15075621 [TBL] [Abstract][Full Text] [Related]
40. The novel H Marino A; Martelli A; Citi V; Fu M; Wang R; Calderone V; Levi R Br J Pharmacol; 2016 Nov; 173(22):3222-3234. PubMed ID: 27548075 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]